BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Total Revenue

See how CATB's total revenue trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$706000.00

As of Sep 2025

Annual Revenue (TTM)

N/A

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Catabasis Pharmaceuticals (CATB) FAQ

Stockcircle tracks total revenue for Catabasis Pharmaceuticals (CATB), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Total Revenue page is built for Catabasis Pharmaceuticals's historical total revenue trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use total revenue as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CATB overview so you can move from this figure to the surrounding analysis quickly.